A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT02837783 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient enrollment

Conditions

Irritable Bowel Syndrome Characterized by Constipation

Interventions

DRUG: Linaclotide
DRUG: Placebo

Sponsor

Ironwood Pharmaceuticals, Inc.

Collaborators

[object Object]